BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 31584979)

  • 1. The investment case as a mechanism for addressing the NCD burden: Evaluating the NCD institutional context in Jamaica, and the return on investment of select interventions.
    Hutchinson B; Small R; Acquah K; Sandoval R; Nugent R; Davidson T; Belausteguigoitia DI; Banatvala N; Webb D; Tarlton D; Kulikov A; Prieto E; Santi K
    PLoS One; 2019; 14(10):e0223412. PubMed ID: 31584979
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An analysis of policy and funding priorities of global actors regarding noncommunicable disease in low- and middle-income countries.
    Jailobaeva K; Falconer J; Loffreda G; Arakelyan S; Witter S; Ager A
    Global Health; 2021 Jun; 17(1):68. PubMed ID: 34187499
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The reported impact of non-communicable disease investment cases in 13 countries.
    Troisi G; Small R; Chestnov R; Andreasyan D; Khachatryan H; Phillips EA; Malcolm T; Kol H; Khodjaeva N; Gebremichael M; Worku Tessema A; Workneh AB; Davidson T; Harris M; Ibraeva N; Nurmatova A; Altymysheva A; Go JJ; Kontsevaya A; Hanbunjerd K; Bunluesin S; Nieveras O; Ekinci B; Keskinkiliç B; Erguder T; Akiya OC; Kasule H; Nakanjako A; Shukurov S; Kasymova N; Banda P; Kakoma E; Bakyaita NN; Kulikov A; Tarlton D; Putoud N; Chiossi S; Webb D; Banatvala N
    BMJ Glob Health; 2024 Apr; 9(4):. PubMed ID: 38599663
    [TBL] [Abstract][Full Text] [Related]  

  • 4. China's Efforts on Management, Surveillance, and Research of Noncommunicable Diseases: NCD Scorecard Project.
    Zhu XL; Luo JS; Zhang XC; Zhai Y; Wu J
    Ann Glob Health; 2017; 83(3-4):489-500. PubMed ID: 29221521
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The case for investing in the prevention and control of non-communicable diseases in the six countries of the Gulf Cooperation Council: an economic evaluation.
    Elmusharaf K; Grafton D; Jung JS; Roberts E; Al-Farsi Y; Al Nooh AA; Bin Belaila B; ElShamy A; Al-Zuabi H; Al Mutawa KA; Alraisi S; Al Lawat N; Gharbal A; Alomary S; Kulikov A; Pourghazian N; Slama S; Tarlton D; Banatvala N
    BMJ Glob Health; 2022 Jun; 7(6):. PubMed ID: 35649631
    [TBL] [Abstract][Full Text] [Related]  

  • 6. NCD Countdown 2030: efficient pathways and strategic investments to accelerate progress towards the Sustainable Development Goal target 3.4 in low-income and middle-income countries.
    NCD Countdown 2030 collaborators
    Lancet; 2022 Mar; 399(10331):1266-1278. PubMed ID: 35339227
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Investing in non-communicable diseases: an estimation of the return on investment for prevention and treatment services.
    Bertram MY; Sweeny K; Lauer JA; Chisholm D; Sheehan P; Rasmussen B; Upreti SR; Dixit LP; George K; Deane S
    Lancet; 2018 May; 391(10134):2071-2078. PubMed ID: 29627159
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevention and control of non-communicable diseases in iran: the case for Investment.
    Yousefi M; Dastan I; Alinezhad F; Ranjbar M; Hamelmann C; Ostovar A; Moghisi A; Mohammadi S; Mataria A; Hammerich A; Slama S; Pourghazian N; Hezaveh AM; Valizadeh B; Torabi P; Najmi M; Moradi M; Hodjatzadeh A; Keshvari-Shad F
    BMC Public Health; 2022 Jun; 22(1):1248. PubMed ID: 35739516
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Correction: The investment case as a mechanism for addressing the NCD burden: Evaluating the NCD institutional context in Jamaica, and the return on investment of select interventions.
    PLOS ONE Staff
    PLoS One; 2020; 15(5):e0233140. PubMed ID: 32379811
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Correction: The investment case as a mechanism for addressing the NCD burden: Evaluating the NCD institutional context in Jamaica, and the return on investment of select interventions.
    Hutchinson B; Small R; Acquah K; Sandoval R; Nugent R; Davidson T; Belausteguigoitia DI; Banatvala N; Webb D; Tarlton D; Kulikov A; Prieto E; Santi K
    PLoS One; 2020; 15(3):e0230270. PubMed ID: 32130267
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Trends in premature avertable mortality from non-communicable diseases for 195 countries and territories, 1990-2017: a population-based study.
    Martinez R; Lloyd-Sherlock P; Soliz P; Ebrahim S; Vega E; Ordunez P; McKee M
    Lancet Glob Health; 2020 Apr; 8(4):e511-e523. PubMed ID: 32199120
    [TBL] [Abstract][Full Text] [Related]  

  • 12. International investment liberalization, transnational corporations and NCD prevention policy non-decisions: a realist review on the political economy of tobacco, alcohol and ultra-processed food.
    Milsom P; Smith R; Baker P; Walls H
    Global Health; 2021 Nov; 17(1):134. PubMed ID: 34819083
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tailored support for national NCD policy and programme implementation: an over-looked priority.
    Jackson-Morris A; Nugent R
    BMJ Glob Health; 2020 Aug; 5(8):. PubMed ID: 32847822
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Healthy people and healthy profits? Elaborating a conceptual framework for governing the commercial determinants of non-communicable diseases and identifying options for reducing risk exposure.
    Buse K; Tanaka S; Hawkes S
    Global Health; 2017 Jun; 13(1):34. PubMed ID: 28619031
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Noncommunicable Disease Prevention and Control in Mongolia: A Policy Analysis.
    Chimeddamba O; Peeters A; Walls HL; Joyce C
    BMC Public Health; 2015 Jul; 15():660. PubMed ID: 26169789
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prioritizing noncommunicable diseases in the Americas region in the era of COVID-19.
    Luciani S; Agurto I; Caixeta R; Hennis A
    Rev Panam Salud Publica; 2022; 46():e83. PubMed ID: 35875322
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Public health concern and initiatives on the priority action towards non-communicable diseases in Tanzania.
    Mfinangai SG; Kivuyo SL; Ezekiel L; Ngadaya E; Mghamba J; Ramaiya K
    Tanzan J Health Res; 2011 Dec; 13(5 Suppl 1):365-77. PubMed ID: 26591991
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Growing global burden of chronic noncommunicable diseases and an alarming situation in China.
    Wang Yf; Lim H; Wu Y
    Beijing Da Xue Xue Bao Yi Xue Ban; 2012 Oct; 44(5):688-93. PubMed ID: 23073576
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.